You just read:

New NCCN Breast Cancer Guidelines Elevate Oncotype DX Breast Recurrence Score® as the Only Preferred Multi-gene Test to Predict Chemotherapy Treatment

News provided by

Genomic Health, Inc.

Oct 09, 2018, 16:15 ET